SYNCHRON LX I 725 CLINICAL SYSTEM
Report
- Report Number
- 2122870-2007-00007
- Event Type
- Other
- Date Received
- January 16, 2007
- Date of Event
- December 22, 2006
- Report Date
- January 16, 2007
- Manufacturer
- BECKMAN COULTER, INC.
- Product Code
- JJE
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TN, US
- Reporter Occupation
- NO INFORMATION
Narratives
A FIELD SERVICE ENGINEER (FSE) WAS IN THE CUSTOMER'S LAB ON 12/22/06. A) THE FSE CONDUCTED A PARTIAL SYSTEM CHECK WHICH PASSED. THE CUSTOMER CALLED BECKMAN COULTER INC. (BC) AND STATED THAT QC WAS OUT ON MULTIPLE ASSAYS ON 12/23/06. CUSTOMER TECHNICAL SERVICE (CTS) HAD CUSTOMER RUN SYSTEM CHECK WHICH FAILED ALL SPECIFICATIONS. CTS HAD CUSTOMER CHECK ASPIRATE PROBES AND THEY FOUND OUT THAT ASPIRATE PROBE #2 WAS MISSING ALONG WITH PERI-PUMP TUBING. A FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO THE CUSTOMER'S LAB ON 12/23/07 TO ADDRESS THE HARDWARE ISSUES. IN A FOLLOW UP WITH THE CUSTOMER ON 01/03/07, THEY STATED THAT THE INSTRUMENT HAS BEEN WORKING WELL SINCE ITS REPAIR. HARDWARE ISSUES ADDRESSED BY THE FSE HAVE CONTRIBUTED TO THIS EVENT.
A CUSTOMER CONTACTED BECKMAN COULTER REGARDING ERRONEOUSLY HIGH TROPONIN (ACCU TNL) RESULTS GENERATED BY THE SYNCHRON LX I 725 INSTRUMENT. A SERIAL DRAWING WAS PERFORMED ON A PT AND ACCU TNL RESULTS WERE OBTAINED AS FOLLOWS: SAMPLE 1: 0.04NG/ML. SAMPLE 2: 0.54NG/ML. SAMPLE 3: "<0.04NG/ML." FOLLOWING THE EVENT, THE CUSTOMER PERFORMED SYSTEM CHECK WHICH FAILED AND NOTED HARDWARE PROBLEMS. THE CUSTOMER THEN SENT ALL SAMPLES OUT OF ANOTHER LAB FOR TESTING. THE CUSTOMER DID NOT RECEIVE ANY REPORT OF PT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PT TREATMENT THAT CAN BE ATTRIBUTED TO OR CONNECTED WITH THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SYNCHRON LX I 725 CLINICAL SYSTEM | DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER | JJE | BECKMAN COULTER, INC. | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA |